These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8245680)

  • 1. Cortisol and hypertension: what was not so apparent about "apparent mineralocorticoid excess".
    Edwards C; Walker B
    J Lab Clin Med; 1993 Dec; 122(6):632-5. PubMed ID: 8245680
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM; Whorwood CB; Walker BR
    Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from licorice.
    Edwards CR
    N Engl J Med; 1991 Oct; 325(17):1242-3. PubMed ID: 1656256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Apparent mineralocorticoid syndrome].
    Shimosawa T; Fujita T
    Ryoikibetsu Shokogun Shirizu; 1996; (12):110-3. PubMed ID: 9047420
    [No Abstract]   [Full Text] [Related]  

  • 7. Mineralocorticoid receptors, salt, and hypertension.
    Funder JW; Krozowski Z; Myles K; Sato A; Sheppard KE; Young M
    Recent Prog Horm Res; 1997; 52():247-60; discussion 261-2. PubMed ID: 9238855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM; Corrie JE; Shackleton CH; Edwards CR
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prismatic case of apparent mineralocorticoid excess.
    New MI
    J Clin Endocrinol Metab; 1994 Jul; 79(1):1-3. PubMed ID: 8027212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency.
    Nikkilä H; Tannin GM; New MI; Taylor NF; Kalaitzoglou G; Monder C; White PC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):687-91. PubMed ID: 8370690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action.
    Benediktsson R; Edwards CR
    Essays Biochem; 1996; 31():23-36. PubMed ID: 9078455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent mineralocorticoid excess syndromes.
    Shimojo M; Stewart PM
    J Endocrinol Invest; 1995; 18(7):518-32. PubMed ID: 9221270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
    Kerstens MN; Dullaart RP
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):509-14. PubMed ID: 10321259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
    Ulick S; Wang JZ; Hanukoglu A; Rösler A
    J Lab Clin Med; 1993 Dec; 122(6):673-6. PubMed ID: 8245686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors.
    Edwards CR; Stewart PM
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):859-65. PubMed ID: 1659446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cure of apparent mineralocorticoid excess by kidney transplantation.
    Palermo M; Cossu M; Shackleton CH
    N Engl J Med; 1998 Dec; 339(24):1787-8. PubMed ID: 9867558
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.
    Speiser PW; Riddick LM; Martin K; New MI
    Metabolism; 1993 Jul; 42(7):843-5. PubMed ID: 8393954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The syndrome of apparent mineralocorticoid excess.
    Cooper M; Stewart PM
    QJM; 1998 Jul; 91(7):453-5. PubMed ID: 9797927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.